Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Krt15+ cells in mice can resist radiation, regenerate tissue, and start tumors, suggesting new cancer treatment targets.

Sonidegib often causes hair loss, and LC-OCT helps identify early signs.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Baricitinib significantly regrows hair in severe alopecia areata patients.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

Carvone helps treat skin issues by reducing melanin and stopping harmful cell growth.

Chemotherapy with carboplatin-paclitaxel causes hair loss in all patients.

Keratinocytes can reduce the survival of certain melanoma cells, suggesting new therapy paths.

The tumor suppressor gene FLCN affects mitochondrial function and energy use in cells.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Tribuloside can increase skin pigmentation by enhancing melanin production and distribution.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Tofacitinib helped a man with alopecia totalis regrow all his hair.

Morroniside may help hair grow and stay in its growth phase by affecting certain cell signals.

Marine compounds from gorgonians and soft corals show promise for drug development, especially for chronic disorders.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Stopping erlotinib improved severe hair loss and skin issues in a patient.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

Researchers found a new gene variant linked to a rare bone disease, which doesn't always cause symptoms in carriers.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

Hedgehog pathway inhibitors can treat certain aggressive cancers but face limitations like resistance and side effects.

ABCG2 protein marks stem-like skin cells in human epidermis.

LGD1069 effectively prevents breast tumors in mice without toxicity.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.